The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
This particular island in the Maldives has poor internet connection.
I meant Stockport, bad part of town.
As if to prove my point!
What a load of rubbish posted today !
Can any one tell me why the sp drop? I am heavily invested here and really believed this would now start heading north! Not south
ta
I don't mean to be dismissive, but you really should go and bone up on what you're invested in.
@Tobethebest
Because AIM is now infested with amateur traders who couldn't give a monkeys about they companies they're invested in. If they think there's going to be no news for a month, they'll sell. These days, trading platforms are just another branch of Paddy Power, inhabited by thickos.
It’s maybe 1% AIM and 99% incompetent management.
I am a lth and believe in the company and you are right it’s the manipulation of the SP by shorting and day traders .
I will be here long term as believe there is a future for Avacta as far as boning up , I have done that’s why surprised at todays massive drop!
“incompetent management”
Haha 😝 won’t be saying that once the first deal is signed and delivered, that’s inevitable.
"won’t be saying that once the first deal is signed and delivered" 100% agree spot on he wont be saying that when as signs the first deal as we will all be dead by the time AL whips out his bloody parker pen ffs.
There wont be one anytime soon Ice anyway as AL is only signing deals if its a decent size one for a gazillion trillion it seems.
Or… it could just do an Alpine Immune Sciences on us.
What’s the rush on deals anyways, we are fully funded going into the pivotal efficacy stage of human trials. We all need to think logically, the more positive data we have available the better the deals we will get longer term. Short term share volatility is only relevant if you are trading or need to sell up, it doesn’t reflect the success the company is going to get if the FDA approves AVA6000. 💯👍
The only thing that's inevitable in this world is that we all end up dead.
Trouble is, will the first deal be signed before that happens.
GLA
Deals are needed as the pipeline is the most important thing and drives the value of the company.
AVA6000 sales WILL NOT begin with this current funding. Another, non dilutive funding, plus external validation will excite the share price and move us forward.
Deals are supremely important. Sitting, collecting data has a shelf life.
We should have a good idea by then if this is a goer or not, so it’s kind of a moot point.
Good point
https://www.jpmorgan.com/content/dam/jpm/commercial-banking/insights/life-sciences/jpmorgan-q2-2023-biopharma-licensing-and-venture-report.pdf
Licensing typically $20|30 bn pQ
Fair chance then
The pipeline is the buyout driver. The FDA will approve it for STS Orphan, generating $100mn/year. People pinning their entire investment case on AVA6000 are too narrow.
More simply, if it failed tomorrow, there is 2 other options via Precision+ and 10s of warheads.
Looks like SH are spooked by the open short - becoming self fulfilling 😠
If it fails tomorrow would the other options be likely to work? I thought this would prove the platform or otherwise
Yes. Dox is a risky drug to improve. Precision can’t fail, it’s already succeeded.
My point is that if anyone is interested in the platform they’re not going to wait for Avacta to be pulling in 100mn in sales before making a move as Avactas position will just become stronger.
So before further dilutive funding is needed, either we get a license deal, we get taken over, or failing that would this just indicate this isn’t of any interest to anyone, and so dilutive funding is the least of our worries.
40p by the end of next week?
MD2000 it's not failed even if the efficacy data isn't great there has been a marked improvement in safety & tolerability over existing dox which would warrant ava6k being licensed albeit after larger trials. It would become SoC
Yadder yadder yadder
The ars ehole is really falling out of this!
Slacker by the end of the month they’ve said they will review the first cohort of the two weekly trial